2026 NPPES data Pharmacist NPI 1104350743 PHARMD
Verify on CMS →

SHAMA AFZAL, PHARMD

Pharmacist in MANTECA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 348 beneficiaries · Pharmacist avg: 135
Generic prescribing
99%
generic claims · 1% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: SHAMA AFZAL, PHARMD is a Pharmacist ([object Object]) practicing in MANTECA, California with a Medicare Part D prescribing footprint of 1K claims across 348 beneficiaries — 1% brand-name prescribing .

What stands out: SHAMA AFZAL, PHARMD filed 1,162 Medicare Part D claims in 2023 across MANTECA, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

SHAMA AFZAL, PHARMD at a glance

Quality data not reported

NPI registry status

Active

Issued 04/19/2017

NPI 1104350743

Primary specialty

Pharmacist

High-volume

290,447 US NPIs in this specialty

Medicare Part D claims

1,162 761% vs specialty avg

2023 prescription claims

Specialty avg: 135

Specialty distribution in California

How Pharmacist compares to other specialties among California providers

California providers

Pharmacist share within California

1. Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SHAMA AFZAL, PHARMD is a Pharmacist provider practicing in MANTECA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARMD. NPI: 1104350743. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SHAMA AFZAL, PHARMD appears in the CMS NPPES registry as a Pharmacist provider holding PHARMD credentials at 1721 W YOSEMITE AVE, MANTECA, CA, 95337, with a listed phone of (209) 824-5061. NPI 1104350743 was issued on 04/19/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AFZAL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,162 prescription claims written by this provider, covering 348 Medicare beneficiaries and totaling roughly $37K in drug spend, split 1% brand-name and 99% generic by claim count, with an opioid prescribing rate of 18.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1721 W YOSEMITE AVE
MANTECA, CA 95337

Provider Details

NPI 1104350743
Specialty Pharmacist
Credentials PHARMD
Gender Female
NPI Issued 04/19/2017

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to SHAMA AFZAL, PHARMD. To verify SHAMA AFZAL, PHARMD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

SHAMA AFZAL, PHARMD — brand share 1.0%
Specialty average (est.)

1% brand-name claims vs 99% generic, on 1,162 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,162
Total Claims
$37K
Total Drug Cost
348
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,675
Total Day Supply
46,275
Brand vs Generic
1% brand / 99% generic
Brand Drug Cost
$5K
Generic Drug Cost
$32K
Opioid Claims
209 (18.0% rate)

Patient Demographics

Average Patient Age
70.0 years
Avg HCC Risk Score
1.41
Gender Split
66% female / 34% male
Age Distribution
<65: 71, 65-74: 170, 75-84: 92, 85+: 15

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Pregabalin
217
Duloxetine Hcl
197
Diclofenac Sodium
144
Gabapentin
101
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
61
Tizanidine Hcl
58
Morphine Sulfate Er
Morphine Sulfate
55
Methocarbamol
49
Venlafaxine Hcl Er
Venlafaxine Hcl
44
Oxycodone Hcl
29

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Overview

How SHAMA AFZAL, PHARMD fits within the Pharmacist landscape nationally.

290,447
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider

SHAMA AFZAL, PHARMD's 1,162 claims are above the specialty average of 135.

Nearby Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as AFZAL.

Compare Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is SHAMA AFZAL, PHARMD's specialty?
SHAMA AFZAL, PHARMD specializes in Pharmacist and practices in MANTECA, California. Credentials: PHARMD.
How much does SHAMA AFZAL, PHARMD prescribe under Medicare Part D?
In 2023, SHAMA AFZAL, PHARMD wrote 1,162 Medicare Part D claims totaling $37K in drug costs for 348 beneficiaries.
Where is SHAMA AFZAL, PHARMD located?
SHAMA AFZAL, PHARMD is located at 1721 W YOSEMITE AVE, MANTECA, CA, 95337. Phone: (209) 824-5061.
What is SHAMA AFZAL, PHARMD's NPI number?
SHAMA AFZAL, PHARMD's National Provider Identifier (NPI) is 1104350743, issued on 04/19/2017.
Does SHAMA AFZAL, PHARMD prescribe more brand-name or generic drugs?
SHAMA AFZAL, PHARMD's prescribing is 1% brand-name and 99% generic drugs by claim count, with $5K in brand drug costs.
Does SHAMA AFZAL, PHARMD prescribe opioids?
Yes, SHAMA AFZAL, PHARMD had 209 opioid claims in 2023 with an opioid prescribing rate of 18.0%.
How many Pharmacist providers are there in the US?
There are 290,447 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does SHAMA AFZAL, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, SHAMA AFZAL, PHARMD's most frequently prescribed drugs include Pregabalin, Duloxetine Hcl, Diclofenac Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SHAMA AFZAL, PHARMD accept Medicare?
SHAMA AFZAL, PHARMD appears in CMS Medicare data with 1,162 Part D claims and 348 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SHAMA AFZAL, PHARMD's credentials?
SHAMA AFZAL, PHARMD's NPI is 1104350743 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology